| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 2 | 15 | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 242 |
| 5 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 253 |
| 531 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| PLP(L) | 212 | 18.4% | 1.22 | 494 | 88.8% |
| Optic-unspecified(L) | 642 | 55.6% | -5.00 | 20 | 3.6% |
| AME(L) | 242 | 21.0% | -5.60 | 5 | 0.9% |
| CentralBrain-unspecified | 41 | 3.6% | -0.15 | 37 | 6.7% |
| ME(L) | 17 | 1.5% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns aMe6a | % In | CV |
|---|---|---|---|---|---|
| aMe4 (L) | 9 | ACh | 294 | 27.2% | 0.3 |
| HBeyelet (L) | 4 | HA | 234 | 21.7% | 0.3 |
| MeVPMe12 (R) | 2 | ACh | 169 | 15.6% | 0.0 |
| OCG02c (R) | 2 | ACh | 54 | 5.0% | 0.7 |
| MeVPaMe2 (R) | 1 | Glu | 47 | 4.4% | 0.0 |
| aMe12 (L) | 4 | ACh | 45 | 4.2% | 0.3 |
| OA-AL2i3 (L) | 2 | OA | 35 | 3.2% | 0.1 |
| MeVCMe1 (R) | 2 | ACh | 26 | 2.4% | 0.4 |
| MeVC20 (L) | 2 | Glu | 22 | 2.0% | 0.5 |
| aMe1 (L) | 2 | GABA | 19 | 1.8% | 0.7 |
| MeVCMe1 (L) | 2 | ACh | 18 | 1.7% | 0.6 |
| OCG02c (L) | 2 | ACh | 18 | 1.7% | 0.2 |
| LoVC20 (R) | 1 | GABA | 10 | 0.9% | 0.0 |
| LPT51 (L) | 2 | Glu | 10 | 0.9% | 0.4 |
| SLP003 (L) | 1 | GABA | 9 | 0.8% | 0.0 |
| aMe30 (L) | 3 | Glu | 8 | 0.7% | 0.2 |
| LoVP96 (L) | 1 | Glu | 7 | 0.6% | 0.0 |
| aMe5 (L) | 5 | ACh | 7 | 0.6% | 0.6 |
| PLP080 (L) | 1 | Glu | 4 | 0.4% | 0.0 |
| PLP246 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| aMe6b (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 3 | 0.3% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 3 | 0.3% | 0.0 |
| MeVP5 (L) | 2 | ACh | 3 | 0.3% | 0.3 |
| MeVP4 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| PS272 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| aMe6c (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| CL063 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| DNp32 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| AN27X013 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LoVC23 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| aMe2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| DNc01 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| MeVP3 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LPC2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| AOTU055 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVP11 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2g1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm26 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SAD044 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe17b (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| aMe3 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe12 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LT58 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP57 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC21 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| l-LNv (R) | 1 | unc | 1 | 0.1% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 1 | 0.1% | 0.0 |
| DNpe053 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns aMe6a | % Out | CV |
|---|---|---|---|---|---|
| aMe30 (L) | 3 | Glu | 249 | 18.2% | 0.3 |
| PLP080 (L) | 1 | Glu | 173 | 12.7% | 0.0 |
| LoVP96 (L) | 1 | Glu | 147 | 10.8% | 0.0 |
| aMe1 (L) | 2 | GABA | 118 | 8.6% | 0.4 |
| DNpe021 (L) | 1 | ACh | 86 | 6.3% | 0.0 |
| LoVP53 (L) | 1 | ACh | 49 | 3.6% | 0.0 |
| KCg-s1 (L) | 1 | DA | 47 | 3.4% | 0.0 |
| OCG02c (R) | 2 | ACh | 33 | 2.4% | 0.2 |
| PLP211 (L) | 1 | unc | 28 | 2.1% | 0.0 |
| aMe2 (L) | 2 | Glu | 27 | 2.0% | 0.7 |
| SLP250 (L) | 1 | Glu | 26 | 1.9% | 0.0 |
| AOTU054 (L) | 2 | GABA | 25 | 1.8% | 0.2 |
| LoVP100 (L) | 1 | ACh | 23 | 1.7% | 0.0 |
| aMe_TBD1 (L) | 1 | GABA | 22 | 1.6% | 0.0 |
| MeVC20 (L) | 2 | Glu | 21 | 1.5% | 0.3 |
| CB3001 (L) | 1 | ACh | 15 | 1.1% | 0.0 |
| LT58 (L) | 1 | Glu | 15 | 1.1% | 0.0 |
| LoVP50 (L) | 3 | ACh | 15 | 1.1% | 0.6 |
| MeVC21 (L) | 2 | Glu | 14 | 1.0% | 0.6 |
| LoVP38 (L) | 2 | Glu | 12 | 0.9% | 0.8 |
| PLP250 (L) | 1 | GABA | 11 | 0.8% | 0.0 |
| OCG02c (L) | 2 | ACh | 10 | 0.7% | 0.0 |
| WEDPN6B (L) | 1 | GABA | 9 | 0.7% | 0.0 |
| LPT51 (L) | 1 | Glu | 9 | 0.7% | 0.0 |
| DNb05 (L) | 1 | ACh | 8 | 0.6% | 0.0 |
| Lat2 (L) | 2 | unc | 8 | 0.6% | 0.0 |
| SLP003 (L) | 1 | GABA | 7 | 0.5% | 0.0 |
| MeVP12 (L) | 5 | ACh | 7 | 0.5% | 0.3 |
| aMe5 (L) | 4 | ACh | 6 | 0.4% | 0.3 |
| MeVPMe11 (R) | 1 | Glu | 5 | 0.4% | 0.0 |
| aMe17c (L) | 2 | Glu | 5 | 0.4% | 0.6 |
| MeVP4 (L) | 4 | ACh | 5 | 0.4% | 0.3 |
| DNp27 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| LoVP81 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| aMe13 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| MeVP32 (L) | 1 | ACh | 4 | 0.3% | 0.0 |
| aMe8 (L) | 2 | unc | 4 | 0.3% | 0.5 |
| Lat1 (L) | 2 | unc | 4 | 0.3% | 0.5 |
| aMe17b (L) | 2 | GABA | 4 | 0.3% | 0.5 |
| LoVP83 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| MeLo1 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| SLP249 (L) | 1 | Glu | 3 | 0.2% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 3 | 0.2% | 0.0 |
| LAL047 (L) | 1 | GABA | 3 | 0.2% | 0.0 |
| DNp31 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| LoVC18 (L) | 2 | DA | 3 | 0.2% | 0.3 |
| aMe4 (L) | 3 | ACh | 3 | 0.2% | 0.0 |
| MeVP5 (L) | 3 | ACh | 3 | 0.2% | 0.0 |
| MeVC23 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| WEDPN11 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| PLP037 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| PLP142 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| SMP200 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| aMe3 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| Lat5 (L) | 1 | unc | 2 | 0.1% | 0.0 |
| LoVC23 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeVP29 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| CL365 (L) | 1 | unc | 2 | 0.1% | 0.0 |
| LoVP54 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| LPT60 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| CL063 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVP28 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP3 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| PLP069 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| DNp32 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LoVP28 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP246 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe22 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP144 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| AOTU058 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL125 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB4073 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP44 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LC37 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm23 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL283_a (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC24 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeLo6 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP14 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LPT111 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVP11 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP045 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| s-LNv (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| ATL042 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| l-LNv (L) | 1 | unc | 1 | 0.1% | 0.0 |
| aMe10 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SAD044 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe24 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL012 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LT72 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP30 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe15 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe20 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe12 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP49 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LT88 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP079 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC22 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| AN19B019 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 1 | 0.1% | 0.0 |
| aMe17e (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| aMe17a (L) | 1 | unc | 1 | 0.1% | 0.0 |
| mALD1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |